Our portfolio

Expanded LMIC access to novel oral poliovirus vaccine

BioFarma received foundation support to expand access to its novel oral poliovirus vaccine type 2 (nOPV2) for the Global Polio Eradication Initiative.
Website
  • Domain
    Healthcare Delivery
  • Investment type
    Volume guarantee
  • Status
    Exit
  • Initial investment
    Private
  • Partnered in
    2022
  • Investment lead
    Chris Chen
  • Headquarters
    Indonesia
  • Program strategy
    Polio

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.